Cancer Prevention and Control (CP) Program

 

 

The Markey Cancer Center’s (MCC) Cancer Prevention and Control (CP) Research Program fosters high-impact, population-based and community-engaged research to reduce cancer disparities in Kentucky.


 

PROGRAM LEADERS ►

dr krystle kuhs
Krystle Kuhs, PhD, MPH
View research profile »

dr jessica burris
Jessica Burris, PhD
View research profile »

The overarching goal of the CP Research Program is to foster high-impact, community-engaged research that spans the population science translation pipeline, from advancing the understanding of risk factors, identifying intervention targets, then developing and testing new interventions, to studying the process of dissemination and implementation of evidence-based interventions in practice. 

Specific Aims

  1. Advance the understanding of risk factors and intervention targets for cancer prevention and control.
  2. Develop and test the efficacy of interventions across the cancer control continuum.
  3. Study the dissemination and implementation of evidence-based interventions.

The CP Research Program has members across the University of Kentucky campus, representing eight colleges and fifteen departments. 

Markey Research Member profiles can be accessed through the Scholars@UK platform. Click below to see the CP members and their profiles.

View CP Members

The CP Program’s monthly meetings are designed to facilitate new research proposals and to encourage collaborations between CP members and the members of Markey’s other research programs. 

If you would like to be added to the mailing list for the CP Program and receive meeting dates and times, please contact Dr. Jerod Stapleton and Dr. Krystle Kuhs.

CP members actively participate in the following Transdisciplinary Working Groups and collaborative groups:

  • Breast
  • Gastrointestinal
  • Prostate
  • Lung
  • Molecular Tumor Board
  • Pediatric Molecular Tumor Board
  • ORIEN/Total Cancer Care
  • Technology Interest Group
  1. Grow the program in prioritized areas of emerging research strengths including molecular/genetic epidemiology, implementation science and health policy
  2. Increase intra- and inter-programmatic interactions, and 
  3. Provide resources and support to increase investigator-initiated NCI grants, especially multi-PI grants.
NCI Comprehensive Cancer Center - A Cancer Center Designated by the National Cancer Institute

Markey Cancer Center is designated by the National Cancer Institute as a Comprehensive Cancer Center – a distinction that recognizes our commitment to accelerating precision cancer research and care to patients. We are the first and only NCI-Comprehensive Cancer Center in Kentucky, and one of 56 in the nation.

LEARN MORE